Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis

IMPORTANCE: Overall, immunotherapy has been shown to improve outcomes and reduce relapses in individuals with N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis (NMDARE); however, the superiority of specific treatments and combinations remains unclear. OBJECTIVE: To map the use and safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nosadini, Margherita, Eyre, Michael, Molteni, Erika, Thomas, Terrence, Irani, Sarosh R., Dalmau, Josep, Dale, Russell C., Lim, Ming, Anlar, Banu, Armangue, Thaís, Benseler, Susanne, Cellucci, Tania, Deiva, Kumaran, Gallentine, William, Gombolay, Grace, Gorman, Mark P., Hacohen, Yael, Jiang, Yuwu, Lim, Byung Chan, Muscal, Eyal, Ndondo, Alvin, Neuteboom, Rinze, Rostásy, Kevin, Sakuma, Hiroshi, Sartori, Stefano, Sharma, Suvasini, Tenembaum, Silvia Noemi, Van Mater, Heather Ann, Wells, Elizabeth, Wickstrom, Ronny, Yeshokumar, Anusha K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453367/
https://www.ncbi.nlm.nih.gov/pubmed/34542573
http://dx.doi.org/10.1001/jamaneurol.2021.3188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453367/
https://www.ncbi.nlm.nih.gov/pubmed/34542573
http://dx.doi.org/10.1001/jamaneurol.2021.3188

Ejemplares similares